PTPRG and Miyoshi myopathy: Nonetheless, this druggability has not been comprehensively explored in MM and therapeutic value of targeting in PTPRG will require preclinical studies (target engagement, selectivity, delivery) followed by appropriately designed early-phase clinical trials.